Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

dicoumarol/infarction

Veza se sprema u međuspremnik
ČlanciKlinička ispitivanjaPatenti
10 rezultatima

[Letter: Dicoumarol therapy following myocardial infarct].

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se

Use of dicoumarol in myocardial infarction.

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se

Bilateral adrenal hemorrhage complicating dicoumarol therapy for myocardial infarction.

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se

[PROLONGED DICOUMAROL AND PELENTAN THERAPY OF MYOCARDIAL INFARCTION AND CHRONIC CORONARY INSUFFICIENCY PATIENTS].

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se

The effect of long term treatment with dicoumarol in myocardial infarction; a controlled clinical study.

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se

Investigations of antithrombin III-activity in patients after myocardial infarction and a long-term coumarin therapy.

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
In 40 M.I. patients with long-term anticoagulant treatment, (Falithrom), the AT III-activity was determined at an interval of three years by means of Chromozym TH. We have found a mean AT III-value in the first testing period of 79.67 (+/- 14.16) per cent and in the second assessment of 82.5 (+/-

Antiplatelet drugs or dicoumarol: what is the most effective prophylaxis in occlusive arterial disease?

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Arterial thromboses lead to disturbances of vital function: myocardial infarction, ischemic cerebral infarction, disorders of peripheral blood flow, nephrosclerosis. Prophylaxis of thrombosis is still an unsolved problem, since diseases caused by thrombosis remain the first cause of death, at least

Clinically significant drug interactions with the oral anticoagulants.

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Oral anticoagulants were introduced in the late 1940s and remain widely used today. Indications include prevention of thrombosis associated with atrial fibrillation, structural cardiac diseases and following prosthetic valvular replacement. They have been used for both treatment and prophylaxis of

Residual coronary stenosis after thrombolysis with rt-PA or streptokinase: acute results and 3 weeks follow-up.

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
Ninety-one patients with acute myocardial infarction were assigned to intravenous treatment with streptokinase or rt-PA as part of the randomized trial carried out by the European Study Group for Recombinant Tissue-Type Plasminogen Activator (rt-PA). A patent coronary artery was found in 37 of 45
A direct involvement of the antioxidant enzyme NAD(P)H:quinone oxidoreductase (NQO1) in neuroprotection has not yet been shown. The aim of this study was to examine changes, localization and role of NQO1 after different neuronal injury paradigms. In primary cultures of rat cortex the activity of
Pridružite se našoj
facebook stranici

Najkompletnija baza ljekovitog bilja potpomognuta znanošću

  • Radi na 55 jezika
  • Biljni lijekovi potpomognuti znanošću
  • Prepoznavanje bilja slikom
  • Interaktivna GPS karta - označite bilje na mjestu (uskoro)
  • Pročitajte znanstvene publikacije povezane s vašom pretragom
  • Pretražite ljekovito bilje po učincima
  • Organizirajte svoje interese i budite u toku s istraživanjem vijesti, kliničkim ispitivanjima i patentima

Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Svi podaci temelje se na objavljenim znanstvenim istraživanjima

Google Play badgeApp Store badge